Moderna Ebola Trial Tests a Vaccine Gap Exposed by Congo Outbreak
Moderna has begun the first human trial of its experimental vaccine against Bundibugyo virus disease at a moment when the Democratic Republic of Congo is facing one of the fastest-growing Ebola outbreaks ever recorded. The trial is significant because the strain driving the outbreak has no licensed vaccine specifically approved against it, leaving health authorities…


